80 FR 44359 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 143 (July 27, 2015)

Page Range		44359-44359
FR Document		2015-18245

Federal Register, Volume 80 Issue 143 (Monday, July 27, 2015)

[Federal Register Volume 80, Number 143 (Monday, July 27, 2015)]
[Notices]
[Page 44359]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-18245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; E01 Parkinson's Disease Biomarker 
Samples.
    Date: July 30, 2015.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Joel A. Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3205, MSC 9529, Bethesda, MD 20892-9529, 301-435-9223, 
joel.saydoff@nih.gov.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; K99/R00 Review.
    Date: July 31, 2015.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Elizabeth A Webber, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3208, MSC 9529, Bethesda, MD 20892-9529, 301-496-1917, 
webbere@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: July 21, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-18245 Filed 7-24-15; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 143 / Monday, July 27, 2015 / Notices 44359

Delegations of Authority Dated: July 21, 2015. Related to Neurological Disorders; 93.854,
Carolyn Baum, Biological Basis Research in the
All delegations of authority and re- Program Analyst, Office of Federal Advisory Neurosciences, National Institutes of Health,
delegations of authority made to HRSA Committee Policy. HHS)
officials that were in effect immediately [FR Doc. 2015–18244 Filed 7–24–15; 8:45 am] Dated: July 21, 2015.
prior to this reorganization, and that are BILLING CODE 4140–01–P Carolyn Baum,
consistent with this reorganization, Program Analyst, Office of Federal Advisory
shall continue in effect pending further Committee Policy.
re-delegation. DEPARTMENT OF HEALTH AND [FR Doc. 2015–18245 Filed 7–24–15; 8:45 am]
This reorganization is effective upon HUMAN SERVICES BILLING CODE 4140–01–P
date of signature.
National Institutes of Health
Dated: July 15, 2015.
DEPARTMENT OF HEALTH AND
James Macrae, National Institute of Neurological
HUMAN SERVICES
Acting Administrator. Disorders and Stroke; Notice of Closed
[FR Doc. 2015–18415 Filed 7–24–15; 8:45 am]
Meetings National Institutes of Health
BILLING CODE 4165–15–P Pursuant to section 10(d) of the
Federal Advisory Committee Act, as National Institute on Drug Abuse;
amended (5 U.S.C. App.), notice is Notice of Meeting
DEPARTMENT OF HEALTH AND hereby given of the following meetings. Pursuant to section 10(d) of the
HUMAN SERVICES The meetings will be closed to the
Federal Advisory Committee Act, as
public in accordance with the
amended (5 U.S.C. App.), notice is
National Institutes of Health provisions set forth in sections
hereby given of a meeting of the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institute of Arthritis and National Advisory Council on Drug
as amended. The grant applications and
Musculoskeletal and Skin Diseases; Abuse.
the discussions could disclose
Notice of Closed Meeting confidential trade secrets or commercial The meeting will be open to the
property such as patentable material, public as indicated below, with
Pursuant to section 10(d) of the and personal information concerning attendance limited to space available.
Federal Advisory Committee Act, as individuals associated with the grant Individuals who plan to attend and
amended (5 U.S.C. App.), notice is applications, the disclosure of which need special assistance, such as sign
hereby given of the following meeting. would constitute a clearly unwarranted language interpretation or other
invasion of personal privacy. reasonable accommodations, should
The meeting will be closed to the
notify the Contact Person listed below
public in accordance with the Name of Committee: National Institute of in advance of the meeting.
provisions set forth in sections Neurological Disorders and Stroke Special
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel; E01 Parkinson’s Disease The meeting will be closed to the
as amended. The grant applications and Biomarker Samples. public in accordance with the
the discussions could disclose Date: July 30, 2015. provisions set forth in sections
Time: 1:00 p.m. to 3:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
confidential trade secrets or commercial
Agenda: To review and evaluate grant as amended. The grant applications
property such as patentable material, applications.
and personal information concerning and/or contract proposals and the
Place: National Institutes of Health,
individuals associated with the grant Neuroscience Center, 6001 Executive discussions could disclose confidential
applications, the disclosure of which Boulevard, Rockville, MD 20852, (Telephone trade secrets or commercial property
would constitute a clearly unwarranted Conference Call). such as patentable material, and
invasion of personal privacy. Contact Person: Joel A. Saydoff, Ph.D., personal information concerning
Scientific Review Officer, Scientific Review individuals associated with the grant
Name of Committee: National Institute of Branch, Division of Extramural Research, applications and/or contract proposals,
Arthritis and Musculoskeletal and Skin NINDS/NIH/DHHS/Neuroscience Center, the disclosure of which would
Diseases Special Emphasis Panel Validation 6001 Executive Boulevard, Suite 3205, MSC
9529, Bethesda, MD 20892–9529, 301–435– constitute a clearly unwarranted
of Pediatric Patient Reported Outcomes in
9223, joel.saydoff@nih.gov. invasion of personal privacy.
Chronic Diseases.
Date: August 13–14, 2015 Name of Committee: National Institute of Name of Committee: National Advisory
Time: 8:00 a.m. to 5:00 p.m. Neurological Disorders and Stroke Special Council on Drug Abuse.
Emphasis Panel; K99/R00 Review. Date: September 1–2, 2015.
Agenda: To review and evaluate grant
Date: July 31, 2015. Closed: September 1, 2015, 1:00 p.m. to
applications. Time: 2:00 p.m. to 4:00 p.m. 4:00 p.m.
Place: Embassy Suites at the Chevy Chase Agenda: To review and evaluate grant Agenda: To review and evaluate grant
Pavilion, 4300 Military Road NW., applications. applications and/or proposals.
Washington, DC 20015. Place: National Institutes of Health, Place: National Institutes of Health,
Contact Person: Kan Ma, Ph.D., Scientific Neuroscience Center, 6001 Executive Neuroscience Center, 6001 Executive
Review Officer, Scientific Review Branch, Boulevard, Rockville, MD 20852, (Telephone Boulevard, Rockville, MD 20852.
National Institute of Arthritis, Conference Call). Open: September 2, 2015, 8:00 a.m. to 2:00
Musculoskeletal and Skin Diseases, NIH, Contact Person: Elizabeth A Webber, Ph.D., p.m.
Scientific Review Officer, Scientific Review Agenda: This portion of the meeting will
tkelley on DSK3SPTVN1PROD with NOTICES

6701 Democracy Boulevard, Suite 814,
Branch, Division of Extramural Research, be open to the public for announcements and
Bethesda, MD 20892, 301–451–4838, mak2@
NINDS/NIH/DHHS/Neuroscience Center, reports of administrative, legislative, and
mail.nih.gov. 6001 Executive Boulevard, Suite 3208, MSC program developments in the drug abuse
(Catalogue of Federal Domestic Assistance 9529, Bethesda, MD 20892–9529, 301–496– field.
Program Nos. 93.846, Arthritis, 1917, webbere@mail.nih.gov. Place: National Institutes of Health,
Musculoskeletal and Skin Diseases Research, (Catalogue of Federal Domestic Assistance Neuroscience Center, 6001 Executive
National Institutes of Health, HHS) Program Nos. 93.853, Clinical Research Boulevard, Rockville, MD 20852.

VerDate Sep<11>2014 18:58 Jul 24, 2015 Jkt 235001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1

Document Created: 2018-02-23 09:26:38
Document Modified: 2018-02-23 09:26:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 30, 2015.
FR Citation		80 FR 44359

80 FR 44359 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 143 (July 27, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health